Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Codex Dna Inc (DNAY)

Codex Dna Inc (DNAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Codex DNA, Inc. (DNAY) Q2 2022 Earnings Call Transcript

DNAY earnings call for the period ending June 30, 2022.

DNAY : 1.3000 (+8.33%)
Codex DNA Reports Second Quarter 2022 Financial Results

SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today reported...

DNAY : 1.3000 (+8.33%)
Codex DNA Showcases Automated Synthetic Biology Solutions for Accelerating Discovery Workflows at the Antibody Engineering and Therapeutics Europe Conference

BioXp™ system and RapidAMP™ cell-free DNA kit rapidly accelerate antibody discovery pipelines by addressing critical bottlenecks associated with lead...

DNAY : 1.3000 (+8.33%)
Codex DNA, Inc. (DNAY) Q1 2022 Earnings Call Transcript

DNAY earnings call for the period ending March 31, 2022.

DNAY : 1.3000 (+8.33%)
Codex DNA to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022

SAN DIEGO, May 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced...

DNAY : 1.3000 (+8.33%)
Codex DNA Unveils Automated Synthetic Biology Solutions for Antibody and Protein Engineering of Biotherapeutic Targets at 18th Annual PEGS Boston Conference and Expo

BioXp™ system and RapidAMP™ cell-free DNA kit allow scientists to synthesize, clone, and amplify antibody-variable regions based on a digital sequence...

DNAY : 1.3000 (+8.33%)
Codex DNA Demonstrates End-to-End Workflow for Storing and Retrieving Data in Synthetic DNA

Proof-of-concept studies go beyond typical DNA data storage projects to ensure high-fidelity data recovery within an automated synthetic biology workflow...

DNAY : 1.3000 (+8.33%)
Codex DNA to Showcase Innovative SOLA Enzymatic DNA Synthesis Technology and Automated Benchtop BioXp System at SynBioBeta’s Built with Biology Global Conference

SOLA approach has the potential to be more accurate, scalable, and cost-effective compared to traditional chemical synthesis and alternative enzymatic...

DNAY : 1.3000 (+8.33%)
Codex DNA, Inc. (DNAY) Q4 2021 Earnings Call Transcript

DNAY earnings call for the period ending December 31, 2021.

DNAY : 1.3000 (+8.33%)

Barchart Exclusives

This Dividend Stock Yielding Almost 3% Is Outperforming In 2026: Should You Buy?
American Electric Power Company stock is up around 14% for the year and has a healthy dividend yield of just under 3%. Is the stock a buy? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar